Abstract
This is the third article in a series of four on interventional nuclear medicine. Upon completion, the technologist will be able to (1) discuss the purpose of using acetazolamide with technetium-99m HMPAO brain imaging, (2) describe the imaging parameters, and (3) list the interpretation criteria.